decisionhealth Newsletters, Answer Books - 2008 Issue 5 (May)
National_Coverage_Determinations_Manual / ETHYLENEDIAMINE-TETRA-ACETIC_(EDTA)_CHELATION_THERAPY_FOR_TREATMENT_OF_ATHEROSCLEROSIS
Subscribe or sign in to view the full article.
Article Overview
This article presents a Medicare coverage determination from the National Coverage Determinations Manual addressing EDTA chelation therapy and its status for certain cardiovascular and calcific conditions. It is useful for coders, compliance staff, and clinicians who need to understand the general coverage stance and the type of noncovered use discussed in the manual. The entry is brief and serves as a policy reference rather than a coding instruction guide.
Why This Topic Matters
Coverage policy affects whether services tied to this therapy are payable under Medicare and whether documentation, billing, and compliance workflows need special review. Readers can quickly determine whether the topic is relevant before consulting the full manual entry.
What You Will Learn
- The coverage topic addressed by the National Coverage Determinations Manual entry
- The general policy posture described for EDTA chelation therapy
- How this manual entry is positioned as a coverage reference for related billing and compliance review
- The type of clinical context referenced by the determination
Who Should Read This
- Medical coders
- Billing specialists
- Compliance professionals
- Healthcare administrators
- Clinicians
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com